MET is required for the recruitment of anti-tumoural neutrophils.
Ontology highlight
ABSTRACT: Mutations or amplification of the MET proto-oncogene are involved in the pathogenesis of several tumours, which rely on the constitutive engagement of this pathway for their growth and survival. However, MET is expressed not only by cancer cells but also by tumour-associated stromal cells, although its precise role in this compartment is not well characterized. Here we show that MET is required for neutrophil chemoattraction and cytotoxicity in response to its ligand hepatocyte growth factor (HGF). Met deletion in mouse neutrophils enhances tumour growth and metastasis. This phenotype correlates with reduced neutrophil infiltration to both the primary tumour and metastatic sites. Similarly, Met is necessary for neutrophil transudation during colitis, skin rash or peritonitis. Mechanistical
SUBMITTER: Finisguerra V
PROVIDER: S-EPMC4594765 | biostudies-literature | 2015 Jun
REPOSITORIES: biostudies-literature
ACCESS DATA